Skip to main content

Closed

BNTC: Benitec Biopharma Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-9701.1%

ROIC-29.3%

Financially safe

Strong

Debt / equity0.00×

Interest coverage15.7×

Current ratio56.82×

Benitec Biopharma Inc.

BNTCNASDAQ Capital Market·USD·Closed

Benitec Biopharma Inc.

BNTCNASDAQ·USD·Closed

$11.71

−1.26%

$11.71

−$0.15 (1.26%)

52W Range

27thpctl

Volume

0.99×avg

Mkt Cap

402.29MUSD

P/E

-10.5TTM

Div Yield

–ann

52W Range

27thpctl

Volume

0.99×avg

Market Cap

402.29MUSD

P/E Ratio

-10.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings